Hyperbaric Oxygen Therapy for the Adjunctive Treatment of Pyoderma Gangrenosum: A Case Report. | Canada Hyperbarics Skip to main content
Case Study Ostomy/wound management 2016

Hyperbaric Oxygen Therapy for the Adjunctive Treatment of Pyoderma Gangrenosum: A Case Report.

Chiang IH, Liao YS, Dai NT, Chiao HY, Chou CY, Chen SG, et al. — Ostomy/wound management, 2016

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers presented a case report of a 54-year-old woman with pyoderma gangrenosum treated with oral prednisone and adjunctive hyperbaric oxygen therapy.

What They Found

The patient received 20 mg/day of oral prednisone for 1 week, tapered to 10 mg/day for another week, along with 12 sessions of hyperbaric oxygen therapy over 2 weeks. Her wounds healed completely without scarring, demonstrating good wound healing, decreased pain, and reduced need for systemic corticosteroids.

What This Means for Canadian Patients

For Canadian patients with pyoderma gangrenosum, adjunctive hyperbaric oxygen therapy could offer a way to improve wound healing and reduce pain. This approach may also help minimize the long-term use and associated side effects of systemic corticosteroids.

Canadian Relevance

This study has no direct Canadian connection as it was conducted outside of Canada.

Study Limitations

As a single case report, this study's findings cannot be generalized to a larger patient population and lack a control group for comparison.

Was this summary helpful?

Study Details

Study Type Case Study
Category Wound Care
Source Pubmed
PubMed ID 27192719
Year Published 2016
Journal Ostomy/wound management
MeSH Terms Diabetes Complications; Female; Humans; Hyperbaric Oxygenation; Middle Aged; Prednisone; Pyoderma Gangrenosum; Steroids; Wound Healing

Cite This Study

Share

Find a Canadian Clinic Treating Wound Care

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.